Michael K. Racke - Concepedia

Author

Michael K. Racke

The University of Texas Southwestern Medical Center ORCID

Also Known As

Annapurna Poduri, D. Campagnolo, Harold Moses, M K Racke, M RACKE, M Racke, M. K. Racke, M. Racke, M.K Racke, M.K. Racke

272

Publications

17.6K

Citations

H-Index

137

Concepts

All Affiliations

The University of Texas Southwestern Medical Center The Ohio State University The Ohio State University Wexner Medical Center National Institute of Neurological Disorders and Stroke National Institutes of Health

About

Michael K. Racke is an author at The University of Texas Southwestern Medical Center specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	65	6.1K
2	Allergy	18	18	2.6K
3	Health Sciences	3	3	289
4	Social Sciences	2	2	80
5	Public Health	1	1	38

Michael K. Racke

119

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. Michael K. Racke, Adriana Bonomo, Dorothy E. Scott, The Journal of Experimental Medicine Cytokine-induced Immune DeviationT-regulatory CellImmunologyCd4 T Cell ResponsesImmunotherapy	1994	599
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Mark S. Freedman, Edward J. Thompson, Florian Deisenhammer, PubMed	2005	594
T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis Jeffrey M. Critchfield, Michael K. Racke, Juan Carlos Zúñiga‐Pflücker, Science T Cell DeletionT-regulatory CellImmunologyT CellsImmunotherapy	1994	524
Immune surveillance in multiple sclerosis patients treated with natalizumab Olaf Stüve, Christina M. Marra, Keith R. Jerome, Annals of Neurology	2006	434
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1 Michael K. Racke, Suhayl Dhib‐Jalbut, B. Cannella, The Journal of Immunology	1991	379
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells Kamran Ghoreschi, Jürgen Brück, Christina Kellerer, The Journal of Experimental Medicine	2011	348
Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis Asim Diab, Caishu Deng, Jeff D. Smith, The Journal of Immunology	2002	289
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells Yuhong Yang, Jeffrey L. Weiner, Yue Liu, The Journal of Experimental Medicine	2009	273
Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis Olaf Stüve, Christina M. Marra, Amit Bar‐Or, Archives of Neurology	2006	270
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis Robert J. Fox, Christopher S. Coffey, Robin Conwit, New England Journal of Medicine	2018	270

Page 1